These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 7792721

  • 41. Glutamate receptors and Parkinson's disease: opportunities for intervention.
    Marino MJ, Valenti O, Conn PJ.
    Drugs Aging; 2003; 20(5):377-97. PubMed ID: 12696997
    [Abstract] [Full Text] [Related]

  • 42. Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms.
    Starr MS.
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):141-85. PubMed ID: 9620061
    [Abstract] [Full Text] [Related]

  • 43. Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease.
    Greenamyre JT.
    J Neural Transm Gen Sect; 1993; 91(2-3):255-69. PubMed ID: 8099800
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions.
    Simola N, Morelli M, Pinna A.
    Curr Pharm Des; 2008; 14(15):1475-89. PubMed ID: 18537671
    [Abstract] [Full Text] [Related]

  • 48. The other side of the histamine H3 receptor.
    Ellenbroek BA, Ghiabi B.
    Trends Neurosci; 2014 Apr; 37(4):191-9. PubMed ID: 24636456
    [Abstract] [Full Text] [Related]

  • 49. The anatomy of the basal ganglia and Parkinson's disease: a review.
    Lee TK, Chau R, Leong SK.
    Singapore Med J; 1995 Feb; 36(1):74-6. PubMed ID: 7570141
    [Abstract] [Full Text] [Related]

  • 50. 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia.
    Haleem DJ.
    Behav Pharmacol; 2015 Feb; 26(1-2):45-58. PubMed ID: 25503261
    [Abstract] [Full Text] [Related]

  • 51. Glutamatergic influences on the basal ganglia.
    Greenamyre JT.
    Clin Neuropharmacol; 2001 Feb; 24(2):65-70. PubMed ID: 11307040
    [Abstract] [Full Text] [Related]

  • 52. Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease.
    Starr MS, Starr BS, Kaur S.
    Neurosci Biobehav Rev; 1997 Jul; 21(4):437-46. PubMed ID: 9195601
    [Abstract] [Full Text] [Related]

  • 53. Treatment of Parkinson's disease.
    Calne DB.
    N Engl J Med; 1993 Sep 30; 329(14):1021-7. PubMed ID: 8366903
    [No Abstract] [Full Text] [Related]

  • 54. Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.
    Riederer P, Lange KW, Kornhuber J, Danielczyk W.
    Arzneimittelforschung; 1992 Feb 30; 42(2A):265-8. PubMed ID: 1350197
    [Abstract] [Full Text] [Related]

  • 55. Mode of action of adenosine A2A receptor antagonists as symptomatic treatment for Parkinson's disease.
    Mori A.
    Int Rev Neurobiol; 2014 Feb 30; 119():87-116. PubMed ID: 25175962
    [Abstract] [Full Text] [Related]

  • 56. Dopamine/glutamate interactions in Parkinson's disease.
    Lange KW, Kornhuber J, Riederer P.
    Neurosci Biobehav Rev; 1997 Jul 30; 21(4):393-400. PubMed ID: 9195597
    [Abstract] [Full Text] [Related]

  • 57. [Progresses in the study of unbalance of basal ganglia neurotransmitters in Parkinson's disease].
    Sun ZL, Jia J, Yu F.
    Sheng Li Ke Xue Jin Zhan; 2011 Dec 30; 42(6):427-30. PubMed ID: 22363981
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism.
    Bello EP, Casas-Cordero R, Galiñanes GL, Casey E, Belluscio MA, Rodríguez V, Noaín D, Murer MG, Rubinstein M.
    Mol Psychiatry; 2017 Apr 30; 22(4):595-604. PubMed ID: 27431292
    [Abstract] [Full Text] [Related]

  • 60. Dopamine receptor interactions: some implications for the treatment of Parkinson's disease.
    Robertson HA.
    Trends Neurosci; 1992 Jun 30; 15(6):201-6. PubMed ID: 1378662
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.